Gubra
  • Services
    • CRO NASH
    • CRO CKD
    • CRO CVD
    • CRO obesity
    • CRO Diabetes
    • CRO customized services
  • Discovery
    • Target Discovery
    • Drug Discovery
    • StreaMLine
  • Capabilities
    • In vivo pharmacology
    • Histology & Stereology
    • Imaging
    • NGS & Bioinformatics
    • Ex vivo assays
    • Molecular pharmacology
    • Peptide chemistry
    • Gubra video gallery
  • Publications
  • Careers
  • About us
    • Company
    • Leadership
    • Events
    • Webinars
    • News
    • Corporate Social Responsibility
    • CSR Activities
Select Page

Gubra wins EY Entrepreneur of the Year, Region Zealand 2020

YES. WE WON! Gubra is awarded EY Entrepreneur of the Year 2020, Region Zealand for the 2nd year in a row. The digital award ceremony took place 3rd December.    The jury highlights “…the strong and passionate entrepreneur who is behind this year’s regional...

Recent Posts

  • Boehringer Ingelheim and Gubra Join Forces to Identify and Validate Innovative Peptides for the Treatment of Obesity
  • Gubra wins EY Entrepreneur of the Year, Region Zealand 2020
  • Gubra chooses sustainable pension scheme
  • A call for simple and comparable CSR reporting
  • A year of solid financial growth, scientific breakthroughs, and strong green commitment

Recent Comments

    Archives

    • March 2021
    • December 2020
    • June 2020
    • May 2020
    • March 2020
    • October 2019
    • June 2019
    • May 2019
    • June 2018
    • September 2017
    • August 2017
    • June 2016
    • September 2013

    Categories

    • News
    • Press Release

    Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org
    • Company
    • Careers
    • CSR
    • Contact
    • Privacy policy
    © 2021 Gubra
    We use cookies to ensure that we give you the best experience on our website. Please accept usage of cookies before continuing.AcceptNoRead our policy